Drawn to Science: The glycosylation of antibodies Published 2013-04-24 Download video MP4 360p Download video MP4 720p Recommendations 05:11 Unleashing the T-cell army | Cancer immunotherapy at Roche 04:46 Monoclonal antibodies in medicine 03:00 Drawn to Science | T-cell bispecific antibodies 03:29 PD-L1/PD-1 Pathway: A Security Checkpoint 03:27 Drawn to Science | Clinical trials 02:34 Roche Brain Shuttle 03:32 Drawn to Science: Zebrafish - a new model for drug discovery 03:05 Drawn to Science: Target identification in drug discovery 05:50 Roche Pharma Research and Early Development (pRED) at a glance 03:30 Drawn to Science: Innovative clinical trial design 03:05 Drawn to Science | Biomarkers in drug discovery 09:12 Biotech production at Roche in Basel | Find out more 02:12 Cancer immunotherapy | The PD-L1 pathway 03:18 The benefits of using Pharmacokinetic and Pharmacodynamic modeling 01:44 What are antibody-drug conjugates and how do they work against cancer? 02:23 The value of in vitro diagnostics 02:47 Clinical Pharmacology: the right dose for every patient 03:05 The role of the blood-brain barrier in lung cancer treatment 02:40 Roche CEO Severin Schwan | Digitalisation of healthcare 01:34 Roche - Our Business Performance Highlights 2023 Similar videos 19:58 Glycosylation of Antibodies and Impact on Food allergy 00:32 Monoclonal antibody glycosylation: make your analytical life easier! 04:23 GlycanAssure Glycan Analysis Technology 02:59 Drawn to Science: Die Glykosylierung von Antikörpern 16:22 Glycosylation in cancer 01:38 The story of our antibodies 03:21 Glycosylation of immunoglobulin light chains in CAD 04:02 Fast profiling N-glycans in biotherapeutic antibodies by UHPLC-FLD with MS confirmation 06:05 Glycosylation - Carolyn Bertozzi (Berkeley) 06:00 O Linked glycosylation 50:34 Getting Started with Glycan Screening 1:33:57 Glycan Analysis in Biopharma - Challenges and Future Perspectives 14:09 mr i explains: Antibody Structure, How Monoclonal Antibodies are produced and their use in diagnosis 10:37 Coronavirus Spike (S) protein biochemistry part 2: cleavage sites, glycosylation, antibody binding 40:34 Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity More results